Leadership and Staff


IAMI's top-notch leadership has more than 200 years of combined pharmaceutical industry experience. Our unique approach to an academic program structure is receiving recognition nationwide.

Scott Weir, Pharm.D., Ph.D.

• Director | Institute for Advancing Medical Innovation
• Professor | Department of Pharmacology, Toxicology and Therapeutics
• Program Leader | Drug Discovery and Development
• Frank B. Tyler Cancer Research Professor

Dr. Weir brings over 22 years of pharmaceutical industry experience to lead the Institute for Advancing Medical Innovation. His leadership, experience and relationships in industry are paving the way for The University of Kansas Cancer Center to attain its goal of becoming the No. 1 academic generator of oncology drugs.

Dr. Weir joined The University of Kansas Cancer Center in February 2006 to establish and manage a fully integrated drug discovery and development program through the collaboration of researchers, industry partners, regulatory and technology transfer resources. Dr. Weir is the leader of the Drug Discovery and Experimental Therapeutics Research Program.


Michael J. Baltezor, Ph.D.

• Deputy Director | IAMI
• Director | Biotechnology Innovation & Optimization Center

Dr. Baltezor provides leadership for the drug delivery activities at the Biotechnology Innovation & Optimization Center (BIO Center) and works with the other scientific disciplines within IAMI to ensure a seamless transition of new drug candidates from discovery to proof-of-concept.


Tyce Bruns, B.S., M.S.

• Project Director | IAMI

In 2009, Tyce Bruns accepted a position at the University of Kansas as a Project Director for the Institute of Advancing Medical Innovation. Mr. Bruns has more than 14 years experience in working across the spectrum in the pharmaceutical industry, from virtual start-ups to large global organizations.

Mr. Bruns has broad knowledge of the drug development process from working with a wide range of clients, and by establishing an extensive customer base. Projects include early drug development, pre-clinical, formulation development, and NDA enabling activities.


Kevin Schorno, B.A., M.B.A.

• Project Director | IAMI

Kevin Schorno has more than 14 years of drug development experience that encompasses the development process from discovery through clinical proof of concept.

Throughout Mr. Schorno's career, he has managed drug development projects for a diverse group of clients that included virtual start-ups, biotechs and large pharmaceutical originations. The projects included drug discovery, clinical/preclinical formulation development, IND/NDA enabling activities, and Phase I/II clinical studies. Mr. Schorno joined the Institute for Advancing Medical Innovation of the University of Kansas in early 2009.


Melinda Broward, B.S., M.S.

• Project Director | IAMI

Melinda Broward facilitates setting budgets, timelines, goals and milestones between core center, resources, external CROs and researchers. She helps focus teams on process design, setting objectives and conducting experiments to hit milestone timelines for High Throughput Screening, concentration curves, secondary assays and medicinal chemistry evaluation.

Ms. Broward facilitates the flow of reagents and data information from one institution to the other. She has extensive experience in cell-based HTS assays, PK/eAME studies, HPLC sample analysis, GMP/GLP raw material/finished product quality control testing, and lead optimization to assist the team in process planning and goal setting. She has five years of project management experience with the University of Kansas managing HTS Projects.


Robyn Wood, B.G.S.

• Project Director | IAMI

In 2009, Robyn joined the Institute for Advancing Medical Innovation at the University of Kansas as a Project Director.  Ms. Wood has more than 30 years of experience working in drug and device development.  Robyn began her career in the lab doing biopharmaceutical research for a small drug delivery company that was later acquired by Merck Research Labs.  After spending ~ 20 years in the lab, Robyn moved into project management of drug development projects and has worked with companies ranging from small virtual start-ups to large global organizations. Robyn directed Project Management departments for Pharmaceutical Contract Research Companies in the United States and the UK.

Last modified: Sep 23, 2013
Leadership & Staff

Director
• Scott Weir

Deputy Director
• Michael J. Baltezor

Project Directors
• Tyce Bruns
• Kevin Schorno
• Melinda Broward
• Robyn Wood

ID=x4279